13F-HR filed by Rosalind Advisors, Inc.
Rosalind Advisors, Inc. filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-14, with 30 holding rows worth $121,420,416.
- Accession
- 0001622627-24-000005
- Filer
- CIK 1622627
- Filed
- 2024-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 30 entries on the cover page, a total value of $121,420,416 stated on the cover page (in dollars after the unit check, H1), rows summing to $121,420,416 with VALUE read as dollars as filed, 13F file number 028-23857. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LYRA THERAPEUTICS INC | 55234L105 | COM | 1,888,720 | $9,896,893 | dollars as filed | |
| MYOMO INC | 62857J201 | COM NEW | 1,919,910 | $9,618,749 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,128,708 | $8,668,477 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 3,543,685 | $8,327,660 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 360,332 | $7,848,031 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 798,500 | $6,986,875 | dollars as filed | |
| OPTINOSE INC | 68404V100 | COM | 4,885,580 | $6,302,398 | dollars as filed | |
| MEDIWOUND LTD | M68830112 | COMMON STOCK | 606,751 | $6,170,658 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 25,000 | $5,784,500 | dollars as filed | |
| CELLECTAR BIOSCIENCES INC | 15117F807 | COM | 2,005,658 | $5,555,673 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 57,400 | $5,535,082 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 250,000 | $4,970,000 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 1,586,392 | $4,648,129 | dollars as filed | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 533,333 | $4,527,997 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 1,038,828 | $4,321,524 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 300,000 | $3,675,000 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 4,000,000 | $2,880,000 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 925,194 | $2,599,795 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 1,862,425 | $2,495,650 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 16,800 | $2,115,960 | dollars as filed | |
| FORTRESS BIOTECH INC | 34960Q307 | COM NEW | 607,797 | $1,829,469 | dollars as filed | |
| ENVVENO MEDICAL CORPORATION | 29415J106 | COM | 312,091 | $1,604,148 | dollars as filed | |
| Reviva Pharmaceuticals Holdings Inc | 76152G100 | Common Stock | 196,300 | $1,010,945 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607950 | COM | 57,400 | $832,300 | dollars as filed | put |
| Merrimack Pharmaceuticals Inc | 590328209 | Common / Ordinary Stock | 60,000 | $804,600 | dollars as filed | |
| INVESCO QQQ TR | 46090E953 | PUT | 900,000 | $602,000 | dollars as filed | put |
| TALPHERA INC | 00444T209 | COM NEW | 758,966 | $557,840 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 500,000 | $465,000 | dollars as filed | put |
| GERON CORP | 374163103 | COM | 200,000 | $422,000 | dollars as filed | |
| TONIX PHARMACEUTICALS HL | 890260854 | COM | 900,900 | $363,063 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001622627-24-000005 | this filing | 2024-02-14 | acceptance time not in the bulk data set |